FDA Approves Migraine Medicine May 17, 2018 by quixnet FDA Approves Migraine MedicineWall Street Journal Amgen’s new migraine drug is affordably priced at only $6900 a yearCBS News How a Migraine Drug Is Easing the Headache of High PricesBloomberg FDA Approves First Drug Designed to Prevent MigrainesNew York Times Full coverage
